Dialnet (Universidad de la Rioja) · 1987 · 54 citations · 11 references
Open access
MedicineCell BiologyPathologyCartilage RepairEnzymologyHistopathologyArticular Cartilage StructureCartilage BreakdownCartilage DegenerationCartilage InjuriesCartilage MetabolismExtracellular MatrixArticular Cartilage ProteoglycansCartilage Degradation MechanismsCartilage DestructionCartilage Proteoglycan SynthesisExtracellular Matrix BreakdownExtracellular Matrix DegradationProteoglycan DegradationProteoglycans
Anatomically intact, murine patellar cartilage was exposed to human polymorphonuclear leucocytes (PMN) stimulated with formyl-methionyl-leucyl-phenylalanine or Ca-ionophore A-23187. This resulted in an inhibition of chondrocyte proteoglycan synthesis and breakdown of cartilage matrix proteoglycans as shown with 35S-incorporation and autoradiography. These effects could not be inhibited by catalase or superoxide dismutase. A serine protease inhibitor and a specific elastase inhibitor prevented both proteoglycan degradation and chondrocyte damage, indicating that PMN-elastase is the causative agent. It was shown that elastase shed by PMN in close contact with the articular cartilage, can escape from complexing with alpha-1 proteinase inhibitor. We would hypothesize that the elastase owing to its dual action (matrix breakdown and inhibition of chondrocyte metabolism) is a major contributor to enzymatic cartilage destruction in inflammatory disorders.
11
Mario J. Castillo, Kiichiro Nakajima, Morris Zimmerman et al. · Analytical Biochemistry · 1979 · 269 citations
Harold D. Keiser, Robert A. Greenwald, Gad Feinstein et al. · Journal of Clinical Investigation · 1976 · 144 citations · Full text
Medicine, Immunology, Pathology +17
Larry A. Sklar, V.M. McNeil, Algirdas J. Jesaitis et al. · Journal of Biological Chemistry · 1982 · 106 citations · Full text